Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · IEX Real-Time Price · USD
2.440
+0.300 (14.02%)
Apr 5, 2024, 3:59 PM EDT - Market open
Indaptus Therapeutics Employees
Indaptus Therapeutics had 7 employees as of December 31, 2023. The number of employees increased by 1 or 16.67% compared to the previous year.
Employees
7
Change (1Y)
1
Growth (1Y)
16.67%
Revenue / Employee
n/a
Profits / Employee
-$2,139,559
Market Cap
18.19M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 7 | 1 | 16.67% |
| Dec 31, 2022 | 6 | 1 | 20.00% |
| Dec 31, 2021 | 5 | 3 | 150.00% |
| Dec 31, 2020 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Aspira Women's Health | 64 |
| Cara Therapeutics | 55 |
| Biotricity | 55 |
| Kala Pharmaceuticals | 43 |
| GlycoMimetics | 35 |
| iBio, Inc. | 26 |
| Aeterna Zentaris | 12 |
| Synlogic | 6 |
INDP News
- 2 months ago - Indaptus Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 3 months ago - Indaptus Therapeutics Presents Positive Mechanism of Action Data at the American Association for Cancer Research Annual Meeting - GlobeNewsWire
- 4 months ago - Indaptus Therapeutics Previews Positive Mechanism of Action Data to be Presented at the American Association for Cancer Research Annual Meeting - GlobeNewsWire
- 4 months ago - Indaptus Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 months ago - Indaptus Therapeutics Announces Positive Results from Second Cohort of Phase 1 Trial; Company Initiates Multi-Dose Cohort - GlobeNewsWire
- 5 months ago - Indaptus Therapeutics Expands Digital Presence with Launch of Social Media Channels - GlobeNewsWire
- 7 months ago - European Patent Office Approves Key Patent for Indaptus Therapeutics' Platform Technology - GlobeNewsWire
- 9 months ago - Indaptus Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update - GlobeNewsWire